Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $654.25 | 7 | 84.3% |
| Education | $121.87 | 1 | 15.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $244.04 | 2 | $0 (2018) |
| ABBVIE INC. | $146.29 | 2 | $0 (2022) |
| Amgen Inc. | $125.00 | 1 | $0 (2017) |
| Collegium Pharmaceutical, Inc. | $124.47 | 1 | $0 (2018) |
| Tactile Systems Technology Inc | $121.87 | 1 | $0 (2019) |
| PFIZER INC. | $14.45 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $124.90 | 1 | ABBVIE INC. ($124.90) |
| 2021 | $21.39 | 1 | AbbVie Inc. ($21.39) |
| 2019 | $136.32 | 2 | Tactile Systems Technology Inc ($121.87) |
| 2018 | $368.51 | 3 | Janssen Pharmaceuticals, Inc ($244.04) |
| 2017 | $125.00 | 1 | Amgen Inc. ($125.00) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/17/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $124.90 | General |
| Category: NEUROSCIENCE | ||||||
| 01/05/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2019 | Tactile Systems Technology Inc | FLEXITOUCH (Device), ACTITOUCH, ENTRE | Education | In-kind items and services | $121.87 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 02/19/2019 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 11/14/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.04 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/02/2018 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/21/2018 | Collegium Pharmaceutical, Inc. | Xtampza ER (Drug) | Food and Beverage | Cash or cash equivalent | $124.47 | General |
| Category: Opioid Analgesic | ||||||
| 11/29/2017 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 832 | 1,083 | $208,947 | $84,785 |
| 2022 | 12 | 866 | 1,105 | $213,229 | $89,934 |
| 2021 | 10 | 800 | 1,014 | $177,935 | $77,323 |
| 2020 | 14 | 822 | 1,017 | $160,567 | $61,554 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 240 | 472 | $110,920 | $38,433 | 34.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 175 | 175 | $42,000 | $23,417 | 55.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 85 | 87 | $15,620 | $6,573 | 42.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 81 | $12,555 | $4,929 | 39.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 15 | $10,545 | $4,214 | 40.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 96 | 98 | $3,430 | $3,141 | 91.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $5,222 | $2,227 | 42.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 97 | 99 | $6,435 | $903.75 | 14.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 20 | 20 | $900.00 | $641.00 | 71.2% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 11 | 11 | $605.00 | $240.09 | 39.7% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 11 | 11 | $715.00 | $65.79 | 9.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 230 | 445 | $104,575 | $37,199 | 35.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 162 | 162 | $38,880 | $22,239 | 57.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 69 | 90 | $13,950 | $6,054 | 43.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 82 | 83 | $13,280 | $5,815 | 43.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 16 | 16 | $11,040 | $4,449 | 40.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 25 | 25 | $6,900 | $3,314 | 48.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 18 | 18 | $6,714 | $3,190 | 47.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 92 | 93 | $3,255 | $2,924 | 89.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 14 | 14 | $5,390 | $2,479 | 46.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 41 | 41 | $1,575 | $1,262 | 80.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 106 | 107 | $6,955 | $923.73 | 13.3% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2022 | 11 | 11 | $715.00 | $85.22 | 11.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 216 | 412 | $94,570 | $37,329 | 39.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 135 | 135 | $32,400 | $19,371 | 59.8% |
About Dr. Mark Monaco, D.O
Dr. Mark Monaco, D.O is a Family Medicine healthcare provider based in Broomall, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164434874.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Monaco, D.O has received a total of $776.12 in payments from pharmaceutical and medical device companies, with $124.90 received in 2022. These payments were reported across 8 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($654.25).
As a Medicare-enrolled provider, Monaco has provided services to 3,320 Medicare beneficiaries, totaling 4,219 services with total Medicare billing of $313,596. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Broomall, PA
- Active Since 08/12/2006
- Last Updated 05/27/2009
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1164434874
Products in Payments
- Repatha (Biological) $125.00
- UBRELVY (Drug) $124.90
- Xtampza ER (Drug) $124.47
- XARELTO (Drug) $124.04
- FLEXITOUCH (Device) $121.87
- INVOKANA (Drug) $120.00
- VRAYLAR (Drug) $21.39
- LYRICA (Drug) $14.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Broomall
Dr. Scott Kurzrok, Do, DO
Family Medicine — Payments: $25,518
Dr. Joseph Labricciosa, Do, DO
Family Medicine — Payments: $23,129
Dr. Joshua Feinberg, Do, DO
Family Medicine — Payments: $11,348
Dr. Donna Delfin, Do, DO
Family Medicine — Payments: $8,705
Dr. Dionne Curran-Chamoun, D.o, D.O
Family Medicine — Payments: $960.68
Phillip Dobson, Md, MD
Family Medicine — Payments: $511.30